Learn About Oral Etrasimod for Ulcerative Colitis

August 2024

Etrasimod (Velsipity) will be an oral once-daily option for moderate to severe ulcerative colitis (UC) in adults.

Think of it as similar to oral once-daily ozanimod (Zeposia).

These meds will be saved for patients who don’t respond to usual therapies (5-ASA, prednisone, azathioprine, etc) or advanced therapies (biologics, JAK inhibitors, etc).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Insulin Expect Buzz Around the First Once-Weekly Insulin
Med Safety Stay Alert for Demo Meds That Look Like Actual Meds
Immunizations Know What’s New With RSV Vaccines for Older Adults
STIs Be Ready for “Doxy PEP” Rxs to Prevent STIs
Ulcerative Colitis Learn About Oral Etrasimod for Ulcerative Colitis
Practice Improve Your Pharmacy’s Onboarding Process
Cardiology Prevent Mishaps With Meds for Peripheral Artery Disease
NatMed Spotlight Be Prepared With Guidance About Ashwagandha

Learn About Oral Etrasimod for Ulcerative Colitis

Practical advice for a better career, with unlimited access to CE

Table of Contents